AQR Capital Management
PLSE icon

AQR Capital Management’s Pulse Biosciences PLSE Stock Holding History

AQR Capital Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,162
Closed -$164K – 3366
2025
Q1 		$164K Sell
10,162
-505
-5% -$9.41K ﹤0.01% 2929
2024
Q4 		$186K Buy
10,667
+10
+0.1% +$176 ﹤0.01% 2684
2024
Q3 		$187K Sell
10,657
-538
-5% -$9.17K ﹤0.01% 2586
2024
Q2 		$125K Sell
11,195
-1,766
-14% -$16.6K ﹤0.01% 2476
2024
Q1 		$113K Buy
+12,961
New +$119K ﹤0.01% 2326
2018
Q4 		– Sell
-17,309
Closed -$246K – 2256
2018
Q3 		$246K Sell
17,309
-15,227
-47% -$216K ﹤0.01% 2156
2018
Q2 		$493K Sell
32,536
-17,176
-35% -$291K ﹤0.01% 1983
2018
Q1 		$673K Buy
49,712
+6,358
+15% +$121K ﹤0.01% 1816
2017
Q4 		$1.02M Buy
43,354
+24,432
+129% +$577K ﹤0.01% 1670
2017
Q3 		$352K Buy
18,922
+10,565
+126% +$240K ﹤0.01% 2041
2017
Q2 		$289K Buy
+8,357
New +$230K ﹤0.01% 2050

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

AQR Capital Management's PLSE Position: Q2 2025 in Review

AQR Capital Management sold out of Pulse Biosciences (PLSE) in Q2 2025, closing a stake of 10,162 shares — an estimated $164K sold.

AQR Capital Management first reported a position in PLSE in Q2 2017 and held it in 11 quarters. The position peaked at $1.02M in Q4 2017. 86 funds tracked by Wall St. Rank hold PLSE as of Q2 2025.

  • AQR Capital Management reported no remaining Pulse Biosciences position as of Q2 2025 after selling out during the quarter.
  • AQR Capital Management sold 10,162 Pulse Biosciences shares in Q2 2025, an estimated $164K.
  • AQR Capital Management first reported a position in Pulse Biosciences in Q2 2017 and held it in 11 quarters.
  • AQR Capital Management's Pulse Biosciences position peaked at $1.02M in Q4 2017.
  • 86 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2025.

Based on AQR Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.